The Ensign Group, Inc.

Greetings and welcome to the Ensign Group Incorporated 3rd Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If you would like to ask a question during that time, please press star followed by number 1 on your telephone keypad. At this time, I would like to turn the call over to Mr. Keech.

Thank you, operator, and welcome, everyone.

We filed our earnings press release yesterday, and it is available on the investor relations section of our website at anzinegroup.net. A replay of this call will also be available on our website until 5 p.m. Pacific on Friday, November 29, 2024. We want to remind anyone that may be listening to a replay of this call that all statements made are as of today, October 25, 2024, and these statements have not been or will be updated subsequent to today's call. Also, any forward-looking statements made today are based on management's current expectations, assumptions, and beliefs about our business and the environment in which we operate. These statements are subject to risks and uncertainties that could cause our actual results to materially differ from those expressed or implied on today's call. Listeners should not place undue reliance on forward-looking statements and are encouraged to review our SEC filings for a more complete discussion of factors that could impact our results. Except as required by federal securities laws, Ensign and its independent subsidiaries do not undertake to publicly update or revise any forward-looking statements where changes arise as a result of new information, future events, changing circumstances, or for any other reason. In addition, the Enzyme Group Inc. is a holding company with no direct operating assets, employees, or revenues. Certain of our independent subsidiaries collectively referred to as a service center provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the other independent subsidiaries through contractual relationships with such subsidiaries. In addition, our captive insurance subsidiary, which we refer to as the insurance captive, provides certain claims made coverage to our operating companies for general and professional liability, as well as for workers' compensation insurance liabilities. Enzyme also owns Standard Barrier Healthcare REIT Inc., which is a captive real estate investment trust that invests in healthcare properties and enters into lease arrangement with certain independent subsidiaries of Enzyme, as well as third-party tenants that are unaffiliated with the Enzyme Group. The words Enzyme, Company, We, Our, and Us refer to the Enzyme Group, Inc., and its consolidated subsidiaries. All of our independent subsidiaries, the Service Center, the Standard Barrier Healthcare REIT, and the Insurance Captive are operated by separate, independent companies that have their own management employees and assets. References herein to the consolidated company and its assets and activities as well as the use of the words we, us, our, and similar terms are not meant to imply nor should it be construed as meaning that the enzyme group has direct operating assets, employees, or revenue, or that any of the subsidiaries are operated by the enzyme group. Also, we supplement our gap reporting with non-gap metrics. When reviewed together with our gap results, we believe that these measures can provide a more complete understanding of our business. They should not be relied upon at the exclusion of gap reports. A gap to non-gap reconciliation is available in yesterday's press release and is available in our Form 10-2. And with that, I'll turn the call over to Barry Port, our CEO. Barry?